Comparison of medication persistence, adherence, and glycemic control among different administration frequencies for DPP-4 inhibitor in patients with type 2 diabetes: A retrospective cohort study of real-world data
Not Applicable
- Conditions
- Type 2 diabetes mellitus
- Registration Number
- JPRN-UMIN000049468
- Lead Sponsor
- Teijin Pharma Limited
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up continuing
- Sex
- All
- Target Recruitment
- 50000
Inclusion Criteria
Not provided
Exclusion Criteria
1. Patients who were designated as having type 1 diabetes during the baseline period 2. Patients who had been prescribed DPP-4 inhibitors (single drug or combination drug) during the baseline period
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 1. Medication persistence (the duration of time from initiation to discontinuation of therapy, the probability of medication persistence) 2. Medication adherence
- Secondary Outcome Measures
Name Time Method Glycemic control